Argos Therapeutics - Ownership and Business Overview

Life ScienceCompany

Argos Therapeutics Ownership

Who owns Argos Therapeutics?

Argos Therapeutics is owned by Genexine. It was acquired on February 13, 2019.

Argos Therapeutics Business Overview

Where is Argos Therapeutics headquartered?

Argos Therapeutics is headquartered in Durham, North Carolina.

What is Argos Therapeutics’ revenue?

Argos Therapeutics disclosed revenue of 2M USD for 2017 and 1M USD for 2016.

How many employees does Argos Therapeutics have?

Argos Therapeutics has 136 employees.

What sector is Argos Therapeutics in?

Argos Therapeutics is a life science company.

When was Argos Therapeutics founded?

Argos Therapeutics was founded in 1997.

Life Science M&A Summary in 2019

Out of 60 sectors in the Mergr database, life science ranked 9 in number of deals in 2019. The largest life science acquisition in 2019 was Celgene - which was acquired by Bristol-Myers Squibb for $74.0B.

Join Mergr to view all 251 acquisitions of life science companies in 2019, including 44 acquisitions by private equity firms, and 207 by strategics.

Argos Therapeutics, Inc.

4233 Technology Drive,
Durham, North Carolina 27704
United States,
(919) 287-6300
www.argostherapeutics.com

Argos Therapeutics, Inc. is a developer of therapeutic vaccines against carcinoma, melanoma, leukemia and HIV. Argos Therapeutics, Inc. was formed in 1997 and is headquartered in Durham, North Carolina.


 Subscribe to unlock this and 208,602
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 201K M&A Transactions
  • 204K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.